All sponsors

EyeBiotech Ltd.

Clinical trial pipeline · active industry-sponsored Phase 1/2 to Phase 3 trials · updated 2026-11-18
ACTIVE TRIALS5
PHASE 3 / 2-34
RECRUITING3
READOUTS ≤12 MONTHS1
Open EyeBiotech Ltd. on the live radar map →
TRIALPHASESTATUSCONDITIONNPRIMARY COMPLETION
BRUNELLO
NCT06571045
P2/3Active, not recruitingDiabetic Macular Edema (DME)9842026-07-14 (-18 mo)
BAROLO
NCT06957080
P2/3Active, not recruitingDiabetic Macular Edema (DME)10542027-01-11 (-18 mo)
Super Tuscan
NCT07205887
P2RecruitingNeovascular Age-Related Macular Degeneration (NVAMD); Branch Retinal Vein Occlusion (BRVO)1602028-06-30
MALBEC
NCT07440225
P2/3RecruitingMacular Degeneration; Age-Related Macular Degeneration9602028-06-30
TORRONTES
NCT07496567
P2/3RecruitingMacular Degeneration; Age-Related Macular Degeneration9602028-07-31